During the past decade, Kantonsspital Freiburg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).
Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy
Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer
2013-09-01
2015-02-01
Completed
229
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Freiburg"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Kantonsspital Freiburg
According to Clinical.Site data, the most researched conditions in "Kantonsspital Freiburg" are
"Breast Cancer" (3 trials), "Lung Cancer" (3 trials), "Prostate Cancer" (2 trials), "Cancer" (1 trials) and "Relapsed Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Kantonsspital Freiburg" in a lesser frequency.
Clinical Trials Intervention Types at Kantonsspital Freiburg
Most popular intervention types in "Kantonsspital Freiburg" are "Drug" (7 trials), "Biological" (3 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab, Cyclophosphamide, Capecitabine" (1 trials), "Chemotherapy" (1 trials), "Durvalumab" (1 trials), "Irinotecan" (1 trials) and "Letrozole" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kantonsspital Freiburg
The vast majority of trials in "Kantonsspital Freiburg" are
5 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Kantonsspital Freiburg
Currently, there are NaN active trials in "Kantonsspital Freiburg".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Kantonsspital Freiburg,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kantonsspital Freiburg, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".